AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Pluri Inc.

Regulatory Filings Sep 13, 2019

6990_rns_2019-09-12_9d28928a-6dad-4cba-a89b-dfd19f8594c9.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

_________ false

�������� ��������� ���� 2 379
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001 8543
- - -
Israel Securities Authority Tel Aviv Stock Exchange C001 ( Public ) Reported via MAGNA: 12/09/2019
www.isa.gov.il www.tase.co.il Reference: 2019-02-079947 Time of broadcast: 23:15 23:12:10

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onPSTI 10K June 30 2019

PSTI_10K_June_30_2019_isa.pdf

Link of EDGAR Filing: _________

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 06/08/2019
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: [email protected]   Company site: www.pluristem.com
Previous names of reporting entity:
Name of the Signatory: Yanay Yaacov Position of Signatory in the reporting corporation: Chief Executive Officer, Director Name of Employer Company:
Address: Matam Park 5 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7108673 E-mail: [email protected] 1

Talk to a Data Expert

Have a question? We'll get back to you promptly.